Regeneron Pharmaceuticals, Inc.
Anti-GITR antibodies and uses thereof
Last updated:
Abstract:
Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.
Status:
Grant
Type:
Utility
Filling date:
26 Jun 2020
Issue date:
16 Aug 2022